G1 Therapeutics, Inc.

NasdaqGS:GTHX Stock Report

Market Cap: US$216.0m

G1 Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:GTHX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Mar 24SellUS$19,752John UmsteadIndividual6,547US$3.02
04 Jan 24SellUS$327John UmsteadIndividual111US$2.94
04 Jan 24SellUS$2,121Terry MurdockIndividual721US$2.94
04 Jan 24SellUS$2,121Mark AvaglianoIndividual721US$2.94
04 Jan 24SellUS$2,121Rajesh MalikIndividual721US$2.94
03 Jan 24SellUS$36,447John BaileyIndividual11,686US$3.12
03 Jan 24SellUS$1,971John UmsteadIndividual632US$3.12
03 Jan 24SellUS$9,416Terry MurdockIndividual3,019US$3.12
03 Jan 24SellUS$10,480Mark AvaglianoIndividual3,360US$3.12
03 Jan 24SellUS$7,526Andrew PerryIndividual2,413US$3.12
03 Jan 24SellUS$9,416Rajesh MalikIndividual3,019US$3.12
02 Jan 24SellUS$108,006John BaileyIndividual32,983US$3.27

Insider Trading Volume

Insider Buying: GTHX insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of GTHX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies6,1000.0117%
Individual Insiders1,178,3662.25%
VC/PE Firms7,166,70413.7%
Institutions12,672,78924.2%
General Public31,280,79859.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 34.78% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.06%
Eshelman Ventures, LLC
4,216,074US$17.4m-6.64%98.57%
5.64%
MedImmune Ventures, Inc.
2,950,630US$12.2m0%100.0%
3.79%
The Vanguard Group, Inc.
1,981,673US$8.2m1.62%no data
3.02%
Susquehanna International Group, LLP, Asset Management Arm
1,578,601US$6.5m0%0.01%
1.53%
Raymond James Financial Inc., Asset Management Arm
802,835US$3.3m42%no data
1.3%
BlackRock, Inc.
680,664US$2.8m-39.2%no data
1.21%
Renaissance Technologies LLC
630,400US$2.6m33%no data
1.05%
Fredric Eshelman
550,000US$2.3m0%no data
1%
Group One Trading LP, Asset Management Arm
521,327US$2.2m1,010%0.06%
0.95%
D. E. Shaw & Co., L.P.
495,451US$2.0m-1.91%no data
0.88%
Geode Capital Management, LLC
460,775US$1.9m4.57%no data
0.81%
abrdn plc
423,869US$1.8m0%no data
0.69%
Marshall Wace LLP
360,293US$1.5m-30.3%no data
0.65%
Schonfeld Strategic Advisors LLC
340,784US$1.4m0%0.01%
0.6%
Jacobs Levy Equity Management Inc
313,068US$1.3m-45.4%0.01%
0.53%
Bank of America Corporation, Asset Management Arm
277,789US$1.1m-2.38%no data
0.43%
Jane Street Group, LLC, Asset Management Arm
222,600US$919.3k2,040%no data
0.37%
Connor, Clark & Lunn Investment Management Ltd.
192,110US$793.4k-5.92%no data
0.35%
Glenn Muir
185,358US$765.5k5.7%no data
0.34%
Needham Investment Management, LLC
180,000US$743.4k-23.1%0.07%
0.34%
Level Four Advisory Services, LLC, Asset Management Arm
178,600US$737.6k-2.62%0.04%
0.33%
Morgan Stanley, Investment Banking and Brokerage Investments
170,058US$702.3k405%no data
0.31%
Two Sigma Investments, LP
162,063US$669.3k79.3%no data
0.31%
State Street Global Advisors, Inc.
161,106US$665.4k0%no data
0.3%
XTX Holdings Limited, Asset Management Arm
157,201US$649.2k-47%0.12%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.